Co-expression of Argonaute2 Enhances Short Hairpin RNA-induced RNA Interference in Xenopus CNS Neurons In Vivo by Chen,  C. M. et al.
NEURAL CIRCUITS
Original research article
published: 09 July 2009
doi: 10.3389/neuro.04.025.2009
Frontiers in Neural Circuits www.frontiersin.org July 2009 | Volume 3 | Article 25 | 1
Co-expression of Argonaute2 enhances short hairpin 
RNA-induced RNA interference in Xenopus CNS 
neurons in vivo
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RNA interference (RNAi) is an evolutionarily conserved mechanism for sequence-specific 
gene silencing. Recent advances in our understanding of RNAi machinery make it possible to 
reduce protein expression by introducing short hairpin RNA (shRNA) into cells of many systems, 
however, the efficacy of RNAi-mediated protein knockdown can be quite variable, especially 
in intact animals, and this limits its application. We built adaptable molecular tools, pSilencer 
(pSi) and pReporter (pRe) constructs, to evaluate the impact of different promoters, shRNA 
structures and overexpression of Ago2, the key enzyme in the RNA-induced silencing complex, 
on the efficiency of RNAi. The magnitude of RNAi knockdown was evaluated in cultured cells 
and intact animals by comparing fluorescence intensity levels of GFP, the RNAi target, relative 
to mCherry, which was not targeted. Co-expression of human Ago2 with shRNA significantly 
enhanced efficiency of GFP knockdown in cell lines and in neurons of intact Xenopus tadpoles. 
Human H1- and U6-promotors alone or the U6-promotor with an enhancer element were equally 
effective at driving GFP knockdown. shRNA derived from the microRNA-30 design (shRNAmir30) 
enhanced the efficiency of GFP knockdown. Expressing pSi containing Ago2 with shRNA 
increased knockdown efficiency of an endogenous neuronal protein, the GluR2 subunit of the 
AMPA receptor, functionally accessed by recording AMPA receptor-mediated spontaneous 
synaptic currents in Xenopus CNS neurons. Our data suggest that co-expression of Ago2 and 
shRNA is a simple method to enhance RNAi in intact animals. While morpholino antisense 
knockdown is effective in Xenopus and Zebrafish, a principle advantage of the RNAi method is 
the possibility of spatial and temporal control of protein knockdown by use of cell type specific 
and regulatable pol II promoters to drive shRNA and Ago2. This should extend the application 
of RNAi to study gene function of intact brain circuits.
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 degradation (Hammond et al., 2000; Zamore et al., 2000). Recent 
studies showed that Argonaute2 (Ago2), a component of RISC, is 
the key enzyme for degradation of target mRNA for gene silencing 
based on its RNase activity (Hammond et al., 2001; Hutvagner and 
Simard, 2008; Liu et al., 2004).
When used as a biological tool, however, the inconsistent effi-
cacy of RNAi in protein knockdown has limited its application. 
One source of variable efficacy apparently comes from the choice 
of shRNA sequences. As a result, it is recommended that at least 
three to six shRNAs for each gene of interest be screened to identify 
those with highest knockdown efficiency (Paddison et al., 2004a). 
Another source of variability is that shRNAs which show effective 
knockdown in cell lines often have lower knockdown efficiency 
in intact animals. Consequently, in Zebrafish and Xenopus, many 
studies have used morpholino antisense oligonucleotides as an 
alternative method for loss-of-function experiments (Anichtchik 
et al., 2008; Bestman and Cline, 2008; Chiu et al., 2008; Kenwrick 
et al., 2004; Nakaya et al., 2008; Wang and Poo, 2005), although 
there are some reports of successful application of shRNAs for 
protein knockdown in Xenopus (Li and Rohrer, 2006; Miskevich 
INTRODUCTION
RNA interference (RNAi) is a natural biological process of sequence-
specific gene silencing triggered by double-stranded RNA (Fire 
et al., 1998). The capability of RNAi to induce loss-of-function 
phenotypes has been developed into a powerful tool to study gene 
function in cell cultures and a variety of organisms (Davidson and 
Boudreau, 2007; Hannon, 2002). Expressing exogenous short hair-
pin RNA (shRNA) in cells can take advantage of endogenous RNAi 
machinery and result in the degradation of target mRNA (Paddison 
et al., 2002). Besides the requirement for Drosha, which cleaves 
microRNA, the endogenous source of double-stranded RNA, into a 
stem-loop precursor of ∼70 nucleotides (Lee et al., 2003; Zeng et al., 
2005), exogenous shRNAs and microRNA share an overlapping 
molecular pathway which involves nuclear export by Exportin 5 
(Lund et al., 2004; Yi et al., 2003) as well as cleavage by Dicer, a 
cytoplasmic RNase, into active double-stranded small interfer-
ing RNAs (siRNA) of ∼ 22 nucleotides in size (Hammond et al., 
2000; Zamore et al., 2000). The antisense strand from the siRNA 
becomes incorporated into a protein complex called RNA-induced 
silencing complex (RISC) and targets the homologous mRNA for 
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et al., 2006). Therefore, the application of RNAi technology would 
be greatly increased by enhancing RNAi efficiency, particularly in 
intact animals. Several attempts have been made to improve RNAi 
efficacy in cultured cells, for example by testing different type of 
promoters (Makinen et al., 2006; Paddison et al., 2004b), struc-
ture of shRNAs (Paddison et al., 2004b; Silva et al., 2005) and co-
 expression of some key components with shRNAs in the RNAi 
machinery (Diederichs et al., 2008; Mikuma et al., 2004; Yi et al., 
2005), however, application of these strategies to study physiologi-
cal gene function in intact animals have not yet been explored.
We have developed an effective strategy to enhance RNAi in 
intact Xenopus. We first built molecular tools to evaluate RNAi 
efficiency in cultured cell lines and tested promoters driving shRNA 
expression and shRNA structures. We also compared the RNAi 
efficiency with co-expression of Ago2, the key enzyme for degrada-
tion of target mRNA. Our data demonstrate that co-expression of 
Ago2 with shRNA targeting GFP significantly enhances the level 
of GFP knockdown compared to expression of the shRNA alone 
in both cultured cell lines and in CNS neurons of intact Xenopus 
tadpoles. We further applied this strategy to test shRNA knockdown 
of the endogenous GluR2 subunit of the AMPA receptors in optic 
tectal neurons of Xenopus tadpoles. While neurons transfected 
with shRNAs against GluR2 have spontaneous AMPA receptor-
 mediated synaptic currents comparable to controls, co-expression 
of GluR2 shRNAs and Ago2 significantly reduced spontaneous 
AMPA  receptor-mediated synaptic currents. Moreover, expression 
of ectopic Ago2 does not affect gross dendritic arbor morphology. 
Together, our results suggest that co-expression of Ago2 and shRNA 
increases the efficacy of RNAi in intact Xenopus CNS. This simple 
 strategy should increase the utility of RNAi in testing gene function 
in  neuronal or circuit development.
MATERIALS AND METHODS
SILENCER CONSTRUCTS
The silencer vector (pSilencer, pSi) was modified from the Clontech 
pEGFP-N1 vector, in which the EGFP and multiple cloning sites 
were removed by BglII and NotI. A SacI site was inserted at posi-
tion 3771 for the promoter cassette to drive shRNAs. Human U6 
(U6) or human H1 (H1) promoters were amplified with 5′ primer 
with SacI and KpnI overhang and 3′ primer with XhoI, EcoRI and 
SacI overhang (Figure 1A) for subsequent cloning into the SacI 
site in the silencer vector to make pSiU6 and pSiH1 constructs. 
To increase the potency of the U6 promoter, the enhancer (En) of 
the cytomegalovirus (CMV) promoter from pEGFP-N1 position 
59–465 was amplified and inserted with the KpnI site in front of 
the promoter cassette of pSiU6 to make the pSiEnU6 construct. 
For constructs with Ago protein expression, multiple cloning sites 
from pEGFP-N1 were removed by BglII and BamHI and EGFP 
was replaced with human Ago1 or Ago2 (gifts from Dr Gregory 
Hannon at Cold Spring Harbor Laboratory) by AgeI and NotI. A 
silent mutation was introduced into Ago2 at the XhoI site in its 
coding region for the subsequent cloning of the shRNA cassette. 
To generate the silencer construct with GFP expression to identify 
transfected neurons, the CMV:GFP with the poly A sequence from 
pEGFP-N1 was PCR amplified and inserted into the AflII site in 
pSiEnU6.
To construct the shRNA cassette, a template  oligonucleotide 
including a 5′ universal primer sequence containing XhoI 
FIguRe 1 | Silencer and reporter constructs used to test RNAi efficacy. 
(A) The silencer construct, pSi, includes two cassettes for easy exchange 
of promoters and shRNAs with or without Ago2 co-expression. The 
shRNA promoter fragments can be inserted into pSi through the SacI site on 
the vector and the shRNA fragments can then be inserted into pSi at XhoI 
and EcoRI sites. (B) The reporter construct, pRe, contains one CMV or NSE 
promoter for GFP expression and another CMV promoter for mCherry 
expression. The GFP silencing effect by shRNAs can be directly 
evaluated by calculating the green to red fluorescence intensity ratio in 
individual cells.
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site (5′ UPS-XhoI; GACAGTGAGCGctcgag), sense sequence, 
loop sequence (CTTCCTGTCA), antisense sequence, termi-
nation signal (TTTTT) and 3′ UPS with EcoRI site (gaattcT-
GCCTACTGCCTC) in order was synthesized (Figure 1A). 
For the GFP knockdown experiments, the sense sequences 
we used were: shGFP-1: CAGCCACAACGTCTATATCATG, 
shGFP-2: CGGCATCAAGGTGAACTTCAAG and shGFP-3: 
GGCAAGCTGACCCTGAAGTTCA. For the GluR2 knock-
down experiment, the sense sequences we used were: 
shGluR2-1: CCGAATGAAGGTGGCAAAGAAT, shGluR2-2: 
CGCAACCTATAAGGAAGGTTAC and shScrambled: AGAG 
CTAAGCGAAATCTCTAGC, which was composed of scrambled 
sequence from shGluR2-2. The oligonucleotides were amplified 
by 5′ and 3′ universal primers containing restriction enzyme sites 
as shown in Figure 1A. PCR products were pooled together for 
restriction enzyme digestion and subsequent cloning into the 
silencer vectors. All positive clones were sequenced. For shRNA 
derived from the artificial microRNA-30 structure (shRNAmir30), 
a fragment from pSM2c, a mir30 sequence containing plasmid, 
including the U6 promoter region and the microRNA region, was 
inserted into pSi vector with SacI. The pSM2c was a generous gift 
from Dr Hannon at Cold Spring Harbor Laboratory. GFP targeting 
sequences were incorporated into pSi as described (Paddison et al., 
2004a; Silva et al., 2005).
REpORTER CONSTRUCTS
The reporter construct (pReporter, pRe) was modified from the 
pBiCS2 vector, a bidirectional plasmid containing two CMV 
promoters in opposite directions. GFP was inserted with BglII/
NheI whereas mCherry was inserted with EcoRI/XbaI after each 
promoter to make pReCMV:mCherry CMV:GFP construct. To 
evaluate RNAi in neurons in intact Xenopus, we made another 
reporter construct with the neuron-specific enolase (NSE) pro-
moter: pReCMV:mCherry NSE:GFP. One CMV promoter from 
pBiCS2 was replaced with the NSE promoter with AscI and HindIII 
sites. In addition, GFP was inserted with EcoRI/XbaI after the NSE 
promoter whereas mCherry was inserted with BglII/NheI after the 
CMV promoter.
CELL CULTURE AND TRANSfECTION
Human embryonic kidney 293 (HEK293), COS7, NIH3T3 or HeLa 
cells were seeded on cover slips in six-well plates and cultivated 
in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, 
Carlsbad, CA, USA) with 10% FBS (Gibco/Invitrogen) until they 
reached ∼70% confluence. Cells were transfected with pSi and 
pRe constructs in a 6:1 molar ratio with Fugene 6 (Roche Applied 
Science, Indianapolis, IN, USA) according to the manufacturer’s 
manual. Forty-eight and seventy-two hours after transfection, 
cells were fixed at room temperature for 15 min with 2% para-
formaldehyde, mounted in ProLong Gold (Invitrogen) and imaged 
with a Zeiss LSM 510 Meta confocal microscope (Carl Zeiss, Jena, 
Germany).
ANIMALS AND NEURONAL TRANSfECTION
Albino Xenopus laevis tadpoles obtained from our lab colony or 
commercial sources (Nasco, Fort Atkinson, WI, USA) were raised 
in an incubator with a 12-h light/12-h dark cycle. Tadpoles were 
staged according to standard criteria (Nieuwkoop et al., 1994). 
Stage 47/48 tadpoles were used for all experiments. For RNAi 
evaluation or electrophysiology in intact tadpoles, bulk tectal cell 
transfections were accomplished by whole brain electroporation 
(Haas et al., 2002) of DNA plasmids. For dendrite morphometric 
experiments, individual optic tectal neurons were transfected by 
single-cell electroporation (Bestman et al., 2006) and only tadpoles 
with single well-labeled tectal neurons were selected for time-lapse 
imaging.
IMAgE qUANTIfICATION
For both cell cultures and intact animals, cells for the same set of 
experiments were imaged with the same settings on the confo-
cal microscope. Single optical images with the highest mCherry 
signals were chosen for each transfected cell and the cell outlines 
were marked according to mCherry fluorescence. For each trans-
fected cell we determined the maximal and averaged green and 
red fluorescence intensities from GFP and mCherry with NIH 
Image J software. Cells with any saturated pixels determined by 
maximal fluorescence intensities in either channel were excluded. 
The averaged green to red (G/R) fluorescence ratio was used as an 
index for RNAi efficiency of GFP knockdown. The G/R ratio from 
shGFPs-transfected cells was normalized to cells transfected with 
the same pSi construct without shRNA {G/R ratio = [(Green
shGFP
/
Red
shGFP
)/(Green
no shRNA
/Red
no shRNA
)] × 100%}. One-way ANOVA 
and post hoc Scheffe’s test (ANOVA-Scheffe’s test) were used to 
test for statistical differences among groups.
MORpHOMETRIC ANALySIS
One day after single-cell electroporation, tectal neurons were 
imaged in vivo using a custom designed laser scanning two-photon 
microscope. Images were collected with Olympus Fluoview soft-
ware (Tokyo, Japan) at 2× zoom and 1.5 μm step-size in the z-axis to 
capture the entire extent of the dendritic arbor. Three-dimensional 
(3D) reconstructions of dendritic arbors were done manually by 
using Object Image software with custom macros (Ruthazer and 
Cline, 2002). The Mann–Whitney test was used to test statistical 
significance between Ago2- and GFP-expressing neuron groups.
ELECTROpHySIOLOgy
Electroporated tadpoles were anesthetized and their brains were 
rapidly dissected out and cut along the dorsal midline to expose 
the optic tectal cell bodies. Brains were constantly perfused with 
HEPES-buffered extracellular solution (115 mM NaCl, 4 mM KCl, 
3 mM CaCl
2
, 3 mM MgCl
2
, 5 mM HEPES, 10 mM glucose, 10 μM 
glycine, pH 7.2 with NaOH, 255 mOsm) containing 1 μM tetro-
dotoxin (Alomone Labs, Jerusalem, Israel) and 100 μM picrotoxin 
(Tocris Biosciences, Ellisville, MO, USA). Whole-cell recording at 
−70 mV holding potential was performed at room temperature 
(21–23°C) using glass micropipettes (6–10 MΩ) filled with internal 
solution (80 mM cesium methanesulfonate, 5 mM MgCl
2
, 20 mM 
tetraethylammonium chloride, 10 mM EGTA, 20 mM HEPES, 
2 mM ATP, 0.3 mM GTP, pH 7.2 with CsOH, 255 mOsm). Three 
to five minutes of recording were analyzed from each cell and 
mEPSCs were detected with a template matching algorithm using 
Clampfit 10.0 (Axon Instruments/Molecular Devices, Sunnyvale, 
CA, USA). Data were normalized by a Box–Cox transformation 
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and subjected to a one-way ANOVA with subsequent pair-wise 
planned comparisons.
RESULTS
BUILDINg TOOLS fOR RNAi
To test RNAi efficacy in vivo, we first constructed a series of tools 
including a “silencer” construct, pSi, for gene silencing and a 
“reporter” construct, pRe, to evaluate knockdown efficiency. The 
pSi contains two easily exchangeable cassettes, the promoter cas-
sette, for testing the effects of different promoters, and the shRNA 
cassette, for testing RNAi efficacy of different shRNAs (Figure 1A). 
The design of the 5′ and 3′ universal primer sequences in our shRNA 
cassette provides a convenient and economical way to amplify can-
didate shRNA sequences together for subsequent cloning in one 
reaction.
We also made a dual-promoter reporter construct expressing 
GFP and mCherry under the control of CMV or NSE promoters 
(Figure 1B) to demonstrate the principle of using cell-type specific 
promoters to drive expression. In addition, we designed three different 
shRNAs against different regions of GFP, termed shGFP-1, shGFP-2, 
shGFP-3. Since our shRNAs are designed specifically to target GFP but 
not mCherry, the green fluorescence intensity from GFP reflects the 
efficacy for RNAi knockdown whereas the red fluorescence intensity 
from mCherry controls for reporter expression level.
AgO2 CO-ExpRESSION ENHANCES RNAi EffICACy IN HEK293 CELLS
To optimize RNAi efficiency, we first tested the effect of different 
promoters in driving shRNAs in HEK293 cells. Human U6 (U6) and 
human H1 (H1) were used to drive shRNAs against GFP. A previ-
ous study has shown that an enhancer from the CMV promoter 
can enhance the U6 promoter activity and increase the synthesis 
of shRNAs (Xia et al., 2003). We therefore made another construct 
adding this enhancer in front of U6 (EnU6) to test whether the 
increased U6 promoter potency can facilitate RNAi efficiency in 
our system.
We co-transfected HEK293 cells with the pSi transcribing 
shGFPs driven by different promoters and the pRe expressing 
GFP and mCherry driven by CMV promoters in the same plasmid 
(Figure 2A). Forty-eight or seventy-two hours after transfection, 
HEK293 cells were fixed and imaged by confocal microscopy to 
calculate the green to red fluorescence intensity ratio (G/R ratio). 
The G/R ratio in shGFP-transfected cells was normalized to that 
in cells transfected with the corresponding pSi, which contains the 
same promoter but no shRNA.
HEK293 cells transfected for 48 h with shGFPs driven by U6, 
EnU6 and H1 promoters show similar degrees of GFP knock-
down efficiency compared to corresponding controls (G/R ratios 
of 13.4–35.9%; Figure 2C and Table 1). Knockdown efficiency was 
only modestly improved by 72 h after transfection (Figure 2C and 
Table 1), suggesting that the knockdown approaches saturation by 
2 days after transfection. These data demonstrate that the type of 
promoter and its potency are not the major determinants control-
ling the RNAi efficiency since U6, with or without enhancer, and 
H1 function comparably.
Overexpression of some key enzymes in the RNAi machinery has 
been used to enhance RNAi efficacy in cultured cells (Diederichs 
et al., 2008; Mikuma et al., 2004; Yi et al., 2005). We tested whether 
co-expression of human Ago2 and shRNA can increase RNAi potency 
using our pRe and pSi constructs. We co-transfected HEK293 cells 
with the pRe expressing GFP/mCherry and a dual-promoter pSi 
expressing shGFPs under the control of the EnU6 promoter and 
either Ago1 or Ago2 under the control of the CMV promoter 
(Figure 2A). Ago2 co- expression with shGFPs produced a dramatic 
decrease in G/R ratios of 4.6–19.8 and 3.4–9.9% in cells transfected 
for 48 and 72 h, respectively (Figures 2B,C red bars and Table 1). 
These effects are specific to Ago2 since HEK293 cells co-expressing 
Ago1, an Ago2 homolog without RNase activity (Liu et al., 2004), 
showed less knockdown (Figures 2B,C yellow bars and Table 1). 
In fact, co- transfection of Ago1 appears to inhibit GFP knockdown 
in HEK293 cells compared to cells without co-transfection of Ago 
protein (Figures 2B,C green bars and Table 1). These results indi-
cate that co-expression of Ago2 increases RNAi efficiency, consistent 
with a previous report in cell lines (Diederichs et al., 2008). The 
results further indicate that Ago1 might interfere or compete with 
endogenous Ago2 function, suggesting that the endogenous levels 
of Ago1 and Ago2 may affect microRNA-mediated protein levels.
CO-ExpRESSION Of AgO2 BROADLy fACILITATES RNAi EffICACy
Previous studies showed that shRNA derived from microRNA-30 
structure (shRNAmir30) increased siRNA production which improves 
RNAi efficiency (Silva et al., 2005). We tested whether shGFPsmir30 
can facilitate GFP knockdown and how effective it is compared to 
Ago2 co-expression in our system. We incorporated the U6-mir30 
fragment from pSM2c with the GFP shRNAs into our pSi con-
structs to generate shGFPsmir30 with or without Ago2 co-expression 
(Paddison et al., 2004a; Silva et al., 2005) (Figure 3A; see Section 
“Materials and Methods” for detail).
HEK293 cells transfected with EnU6-shGFPs for 72 h showed 
GFP knockdown efficiency of 12.8–24.9% (Figure 3B green bars 
and Table 2), however, cells co-transfected with EnU6-shGFPs 
along with Ago2 co-expression showed consistent improvement 
in GFP knockdown to give G/R ratios of 5.4–10.6% for all shGFPs 
tested (Figure 3B red bars and Table 2). By contrast, when cells 
were transfected with U6-shGFPsmir30, GFP knockdown efficiency 
varied depending on the shGFPs tested (Figure 3B yellow bars 
and Table 2). shGFP-1mir30 and shGFP-2mir30 showed improved 
GFP knockdown with G/R ratios of 7.5 and 7.8%, respectively. 
Expression of shGFP-3mir30 did not improve knockdown and these 
cells had a higher G/R ratio of 32.0%. Furthermore, when we co-
transfected cells with Ago2 and shGFPsmir30, the G/R ratios were 
5.0–13.2% for all shGFPsmir30 tested (Figure 3B brown bars and 
Table 2), comparable to cells co-transfected with Ago2 and shGFPs 
(Figure 3B red bars and Table 2). Of note, we also co-expressed 
Ago2 with shGFPs in different cell lines. Although NIH3T3 cells did 
not show improved knockdown efficiency with Ago2 co-expression, 
COS7 and HeLa cell lines increased GFP knockdown efficiency with 
Ago2 co-expression (Table 2), implying that the Ago2 enhancement 
in RNAi can be applied to various experimental systems, but may 
have cell-type specific effects. It is not clear why murine NIH3T3 
cells show lower knockdown efficiency. Ago2 is evolutionarily well 
conserved, with human Ago2 amino acid sequence sharing 99 and 
96% identity to mouse and Xenopus Ago2, suggesting that differ-
ences in Ago2 function in the different cell lines does not account 
for the difference.
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AgO2 CO-ExpRESSION ENHANCES RNAi IN Xenopus TADpOLES 
in vivo
To test whether co-expression of Ago2 enhances RNAi in neurons in 
intact animals, we used live Xenopus laevis tadpoles as a model sys-
tem. Although RNAi has been reported in Xenopus (Li and Rohrer, 
2006; Miskevich et al., 2006), our own attempts and other reports 
suggest it is not efficient (Kenwrick et al., 2004).
We transfected tadpole neurons by electroporation of the pSi 
containing EnU6-shGFPs with or without Ago2 co-expression, 
and the pRe expressing GFP and mCherry under the control of 
NSE and CMV promoters, respectively (Figure 4A). Three or 
five days after electroporation, tadpoles were anesthetized and 
imaged by confocal microscopy. We evaluated the GFP knock-
down efficiency by calculating the intensity ratio of green to red 
fluorescence.
Three days after electroporation, neurons transfected with 
EnU6-shGFP2 or EnU6-shGFP3 did not show significant GFP 
knockdown compared to controls, even though these shRNAs had 
FIguRe 2 | effect of different promoters and Ago2 co-expression in RNAi 
efficacy. HEK293 cells, transfected with pSi and pRe constructs were imaged 
after 48 or 72 h to evaluate GFP knockdown efficiency by the green to red (G/R) 
fluorescence intensity ratio. (A) Diagram of the pSi constructs (left) containing 
U6, enhancer added U6 (EnU6) or H1 promoter driven shGFPs, and the pRe 
construct (right) for simultaneous GFP and mCherry expression. 
(B) Representative images from cells 2 days after transfection of pSi constructs 
containing EnU6 driven shGFPs with or without Ago protein co-expression. 
(C) G/R fluorescence intensity ratio measured from cells transfected with pSi 
constructs with or without Ago protein co-expression. The ratio in 
shGFP-transfected cells was normalized to the averaged G/R ratio from controls 
with no shRNA expression. shGFPs driven by U6, EnU6 and H1 promoters have 
comparable degrees of knockdown. However, EnU6-shGFPs with Ago2 
co-expression show significant increases in GFP knockdown compared to 
EnU6-shGFPs alone or EnU6-shGFPs with Ago1 co-expression. Asterisks 
represent statistical significance (p < 0.05, ANOVA-Scheffe’s test).
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Table 1 | effect of RNAi with different silencer constructs in HeK293 cells.
 Time 48 h 72 h
Silencer constructs g/R ratio (%) n g/R ratio (%) n
pSiU6-Ctrl 100.0 ± 2.6 283 100.0 ± 2.6 308
pSiU6-shGFP-1 35.3 ± 1.1 298  24.3 ± 1.4 198
pSiU6-shGFP-2 17.8 ± 0.7 290 13.4 ± 0.9 170
pSiU6-shGFP-3 15.1. ± 1.1 250 8.5 ± 0.4 168
pSiEnU6-Ctrl 100.0 ± 2.2 300  100.0 ± 4.4 241
pSiEnU6-shGFP-1 32.7 ± 1.2 263 21.8 ± 1.1 187
pSiEnU6-shGFP-2 16.5 ± 0.6 328 16.4 ± 1.1 232
pSiEnU6-shGFP-3 17.0 ± 0.8 254 10.5 ± 0.6 168
pSiH1-Ctrl 100.0 ± 2.9 173 100.0 ± 2.6 208
pSiH1-shGFP-1 35.9 ± 1.5 192 22.4 ± 1.3 173
pSiH1-shGFP-2 18.2 ± 0.9 183 17.0 ± 0.9 168
pSiH1-shGFP-3 13.4 ± 0.6 168 12.8 ± 0.7 193
pSiEnU6-Ctrl CMV-Ago1 100.0 ± 2.0 239 100.0 ± 1.9 234
pSiEnU6-shGFP-1 CMV-Ago1 44.8 ± 1.3 210 56.7 ± 1.9 145
pSiEnU6-shGFP-2 CMV-Ago1 22.0 ± 0.7 230 23.6 ± 1.1 153
pSiEnU6-shGFP-3 CMV-Ago1 31.6 ± 0.9 241 41.1 ± 2.3 175
pSiEnU6-Ctrl CMV-Ago2 100.0 ± 1.4 260 100.0 ± 1.5 237
pSiEnU6-shGFP-1 CMV-Ago2 19.8 ± 1.2 320 9.9 ± 0.9 150
pSiEnU6-shGFP-2 CMV-Ago2 4.6 ± 0.4 224 3.4 ± 0.2 175
pSiEnU6-shGFP-3 CMV-Ago2 8.9 ± 0.5 245 6.6 ± 0.3 244
Note: Data for pSiEnU6-shGFPs, pSiEnU6-shGFPs CMV-Ago1 and pSiEnU6-shGFPs CMV-Ago2 are from an experiment independent from the data plotted in Figure 3 
and Table 2. G/R ratio: green to red fluorescence intensity ratio normalized to controls, which contain no shGFP expression in the same pSi configuration. n, number 
of cell examined.
FIguRe 3 | effect of shRNA structure on RNAi efficacy. (A) Diagram of the pSi 
constructs containing shGFP or shGFPmir30 with or without Ago2 co-expression 
(left), and the pRe construct (right) for simultaneous GFP and mCherry expression. 
(B) G/R fluorescence intensity ratio measured from cells transfected with pSi 
constructs containing shGFP or shGFPmir30 with or without Ago2 co-expression. 
For shGFPs, Ago2 co-expression broadly enhances GFP knockdown (red bars). For 
shGFPsmir30, the RNAi efficiency increases for shGFP-1mir30 and shGFP-2mir30 but not 
shGFP-3mir30 (yellow bars). Additionally, Ago2 co-expression enhances knockdown 
with all shGFPsmir30 to a level comparable to Ago2 co-expression with shGFPs. 
Asterisks represent statistical significance (p < 0.05, ANOVA-Scheffe’s test).
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the highest GFP knockdown efficiency in cell lines (Figures 4B,C 
green bars and Table 3), Neurons transfected with pSi contain-
ing Ago2 and EnU6-shGFPs, had green to red fluorescence ratios 
that were significantly lower than controls (Figures 4B,C red bars 
and Table 3). A minor increase in GFP knockdown was observed 
5 days after electroporation in neurons of living Xenopus tadpoles 
(Figures 4B,C red bars and Table 3), indicating that the RNAi effect 
was close to saturation 3 days after transfection. The enhanced 
RNAi efficiency was Ago2-specific because the G/R ratios in neu-
rons transfected with pSi containing Ago1 and EnU6-shGFPs were 
comparable to controls (Figures 4B,C yellow bars and Table 3).
NEURONS ExpRESSINg ECTOpIC AgO2 ACqUIRE NORMAL DENDRITIC 
MORpHOLOgy
The Xenopus optic tectal system is a well established system to 
study neuronal development in vivo. Numerous studies have dem-
onstrated that the exquisite temporal and spatial regulation of 
multiple genes are required to control the dendritic arborization, 
synaptic connections and proper circuit function (Cline, 2001; Wu 
et al., 1999). To evaluate whether ectopic Ago2 expression affects 
neuron development, we monitored dendritic arbor structure of 
Ago2-transfected neurons in living Xenopus tadpoles using in vivo 
time-lapse imaging. Stage 46/47 tadpoles were electroporated with 
a dual promoter plasmid expressing Ago2 and GFP or GFP alone by 
single cell electroporation. One day after electroporation, animals 
with single labeled neurons were imaged daily with a laser- scanning 
two-photon microscope for 3 days. Dendritic branch lengths and 
branch tip numbers were quantified from 3D reconstructions 
of the dendritic arbor structures from in vivo images. For total 
dendritic branch length, neurons with ectopic Ago2 expression 
had similar branch length to GFP control neurons at each day 
of imaging (Figures 5A,B; GFP: day1/2/3: 371.04 ± 76.67/772.72 
± 111.78/1001.02 ± 86.71; Ago2: day1/2/3: 385.81 ± 51.00/793.29 
± 52.87/986.10 ± 66.34). For the total branch tip number, neu-
rons with ectopic Ago2 expression were also comparable to GFP 
controls (Figures 5A,C; GFP: day1/2/3: 59.89 ± 14.59/121.67 ± 
22.14/153.44 ± 19.07; Ago2: day1/2/3: 63.88 ± 8.18/133.88 ± 9.76/
167.00 ± 11.78). These data indicate that ectopic Ago2 expression 
alone does not interfere with normal dendritic arbor elaboration 
during neuronal development.
AgO2 CO-ExpRESSION ENHANCES RNAi EffICIENCy in vivo
To test whether Ago2 co-expression enhances silencing of endog-
enous genes in Xenopus in vivo, we designed two shRNAs against 
the Xenopus GluR2 subunit of the AMPA receptor, shGluR2-1 and 
shGluR2-2, and a control shRNA, shScrambled, which encoded a 
scrambled sequence from shGluR2-2. AMPA receptors are heter-
otetramers, typically composed of GluR2 subunits combined with 
GluR1 or GluR3 (Hollmann and Heinemann, 1994; Rosenmund 
et al., 1998; Wenthold et al., 1996). We reasoned that GluR2 knock-
down would have a significant effect on AMPA-receptor mediated 
synaptic transmission. Tadpoles were electroporated with pSi con-
taining EnU6-shRNAs for GluR2 knockdown and CMV driven 
GFP for cell identification with or without Ago2 expression under 
Table 2 | effect of RNAi with different silencer constructs containing different promoters or structures of shRNAs in different cell lines.
 Cell types HeK293 COS7 NIH3T3 HeLa
Silencer constructs g/R ratio n g/R ratio n g/R ratio n g/R ratio n
pSiEnU6-Ctrl 100.0 ± 4.2 175 100.0 ± 5.7 132 100.0 ± 4.9 50 100.0 ± 2.4 207
pSiEnU6-shGFP-1 24.9 ± 1.6 155 17.4 ± 1.5 112 24.8 ± 1.7 115 33.2 ± 1.6 127
pSiEnU6-shGFP-2 12.8 ± 0.5 245 17.6 ± 1.5 135 8.9 ± 0.5 137 20.1 ± 1.1 90
pSiEnU6-shGFP-3 16.0 ± 0.5 369 14.1 ± 0.9 100 13.2 ± 1.4 101 23.6 ± 1.7 88
pSiEnU6-Ctrl CMV-Ago1 100.0 ± 5.6 125 100.0 ± 7.2 83 100.0 ± 7.8 52 100.0 ± 6.9 95
pSiEnU6-shGFP-1 CMV-Ago1 53.3 ± 4.5 50 63.5 ± 3.3 119 65.9 ± 4.0 87 59.7 ± 3.6 93
pSiEnU6-shGFP-2 CMV-Ago1 25.5 ± 1.6 119 19.6 ± 1.0 108 49.0 ± 4.3 63 32.8 ± 2.0 101
pSiEnU6-shGFP-3 CMV-Ago1 38.7 ± 2.0 102 24.4 ± 2.9 61 56.9 ± 3.9 72 53.1 ± 3.5 135
pSiEnU6-Ctrl CMV-Ago2 100.0 ± 4.1 195 100.0 ± 5.4 136 100.0 ± 5.9 76 100.0 ± 3.1 224
pSiEnU6-shGFP-1 CMV-Ago2 10.6 ± 0.7 291 9.3 ± 1.0  62 20.0 ± 2.0 44 22.6 ± 1.6  104
pSiEnU6-shGFP-2 CMV-Ago2 5.4 ± 0.5 221 7.0 ± 0.4 121 11.5 ± 0.7 69 13.7 ± 0.8 108
pSiEnU6-shGFP-3 CMV-Ago2 7.5 ± 0.5 90 8.0 ± 0.5 123 13.4 ± 0.9 81 11.6 ± 0.8 87
pSiU6-Ctrl 100.0 ± 4.3 117 100.0 ± 3.3 146 100.0 ± 4.5 63 100.0 ± 3.0 97
pSiU6-shGFP-1mir30 7.5 ± 0.5 196 4.4 ± 0.4 37 10.6 ± 1.4 93 21.5 ± 2.1 101
pSiU6-shGFP-2mir30 7.8 ± 0.5 316 4.6 ± 0.4 75 10.9 ± 0.8 162 24.7 ± 1.7 149
pSiU6-shGFP-3mir30 32.0 ± 2.7 274 32.8 ± 2.0 54 61.1 ± 3.3 89 40.9 ± 2.2 219
pSiU6-Ctrl CMV-Ago2 100.0 ± 2.8 266 100.0 ± 4.0 162 100.0 ± 3.8 116 100.0 ± 3.6 173
pSiU6-shGFP-1mir30 CMV-Ago2 7.8 ± 0.5  214 13.0 ± 1.3 136 34.8 ± 4.9 76 22.3 ± 2.7 153
pSiU6-shGFP-2mir30 CMV-Ago2 13.2 ± 1.1 287 15.3 ± 1.4 104 41.7 ± 4.7 105 22.2 ± 1.9 125
pSiU6-shGFP-3mir30 CMV-Ago2 5.0 ± 0.3 290 9.1 ± 1.6 122 25.2 ± 3.5 97 17.1 ± 2.6 130
Note: Data for pSiEnU6-shGFPs, pSiEnU6-shGFPs CMV-Ago1 and pSiEnU6-shGFPs CMV-Ago2 are from an experiment independent from the data plotted in 
Figure 2 and Table 1. G/R ratio: green to red fluorescence intensity ratio normalized to controls, which contain no shGFP or shGFPmir30 expression in the same pSi 
configuration. n, number of cell examined.
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FIguRe 4 | Ago2 expression enhances RNAi in neurons of living Xenopus 
tadpoles. Neurons, transfected with pSi and pRe constructs, were imaged 
after 3 or 5 days to evaluate GFP knockdown by G/R fluorescence intensity 
ratio. (A) Diagram of the pSi (left) containing EnU6-shGFPs with or without 
Ago protein co-expression, and the pRe (right) for simultaneous GFP and 
mCherry expression. (B) Representative images from CNS neurons 3 days 
after transfection of the pSi constructs as indicated. (C) G/R ratios measured 
from CNS neurons transfected with different pSi constructs driving shGFPs, 
normalized to control cells. Note that the pSi construct containing the 
EnU6-shGFPs and Ago2 (red bars) has greater knockdown than the EnU6 
promoter alone (green bars) or EnU6-shGFPs with Ago1 (red bars). Asterisks 
represent statistical significance between neurons transfected with no 
shRNA and shGFPs with the same silencer configuration (p < 0.05, 
ANOVA-Scheffe’s test).
Table 3 | effect of RNAi using different silencer constructs in CNS neurons of Xenopus tadpoles.
 Time Day 3 Day 5
Silencer constructs g/R ratio (%) n g/R ratio (%) n
pSiEnU6-Ctrl 100.0 ± 9.0 137 100.0 ± 4.6 273
pSiEnU6-shGFP-2 80.3 ± 6.6 246 82.6 ± 5.4 340
pSiEnU6-shGFP-3 85.7 ± 5.7 283 86.8 ± 5.6 252
pSiEnU6-Ctrl CMV-Ago1 100.0 ± 5.9 258 100.0 ± 6.9 150
pSiEnU6-shGFP-2 CMV-Ago1 94.8 ± 5.1 242 93.9 ± 8.5 99
pSiEnU6-shGFP-3 CMV-Ago1 84.1 ± 8.8 167 83.0 ± 6.6 96
pSiEnU6-Ctrl CMV-Ago2 100.0 ± 3.8 146 100.0 ± 7.0 110
pSiEnU6-shGFP-2 CMV-Ago2 67.9 ± 4.2 138 64.0 ± 3.9  123
pSiEnU6-shGFP-3 CMV-Ago2 66.4 ± 2.1 251 61.8 ± 3.6 123
Note: G/R ratio: green to red fluorescence intensity ratio normalized to controls, which contain no shGFP expression in the same pSi configuration. n, number of 
cells examined.
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the control of another CMV promoter (Figure 6A). Conventional 
western blot evaluation of the protein knockdown cannot be used in 
these experiments because of the low and variable transfection effi-
ciency (∼3–10%) with electroporation (Chiu et al., 2008). Isolation 
and enrichment of transfected neurons by FACS for further analysis 
is also not practical due to limited numbers of transfected cells in 
the optic tectum of Xenopus tadpoles. Furthermore, use of light 
microscope immunohistochemistry to evaluate knockdown of 
membrane proteins is not possible in the developing optic tectum 
because the cell bodies are extremely densely packed and it is dif-
ficult to distinguish quantitative changes in immuno-detection in 
membranes of neighboring cells. Therefore, we assessed AMPA 
receptor knockdown functionally by recording the frequency 
and amplitude of AMPA receptor-mediated spontaneous mini-
ature excitatory postsynaptic current (AMPA mEPSC) 3 days after 
transfection.
AMPA mEPSC frequency was significantly lower in neurons 
expressing shGluR2s with Ago2 than in neurons expressing 
shScrambled with Ago2 (Figures 6B,C; Ago2 + shScrambled/
Ago2 + shGluR2-1/Ago2 + shGluR2-2: 1.05 ± 0.23/0.38 ± 0.09/0.39
± 0.10; n = 23, 24, 20) and neurons expressing shGluR2s alone 
(shGluR2-1/shGluR2-2: 0.75 ± 0.14/0.87 ± 0.21; n = 25, 21). 
Furthermore, 2 out of 24 or 3 out of 20 cells transfected with Ago2 
and shGluR2-1 or shGluR2-2 did not have any detectable mEPSC 
FIguRe 5 | Neurons expressing ectopic Ago2 acquire normal dendritic 
arbor structure. Individual optic tectal neurons expressing GFP or GFP + Ago2 
were imaged daily over 3 days in living animals (A). Total dendritic branch length 
(B) and branch tip number (C) were determined on 3D reconstructions of tectal 
neurons. Total branch length and branch tip number are comparable between 
GFP and Ago2-expressing neurons (p > 0.05, Mann–Whitney test).
throughout the 3–5 min recording period (although they have nor-
mal input and access resistances) suggesting a strong knockdown 
effect of endogenous GluR2. On the other hand, neurons express-
ing GFP alone (Figures 6B,C; GFP: 1.22 ± 0.28; n = 18), shGluR2s 
without Ago2 co-expression (Figure 6B,C, black traces and cir-
cles) and neurons expressing scrambled hairpins with Ago2 co-
 expression had similar mEPSC frequencies (Figures 6B,C). These 
data indicate that co-expression of Ago2 facilitates the reduction of 
endogenous GluR2 function and can be applied to intact Xenopus 
system to enhance the RNAi efficiency.
We also compared the frequency of AMPA mEPSC in tectal neu-
rons transfected with GFP alone, Ago2 alone or Ago2 + shScrambled 
co-expression. AMPA mEPSC frequency was comparable between 
these three groups of neurons (Figures 6B,C; GFP/Ago2/
Ago2 + shScrambled: 1.22 ± 0.28/0.74 ± 0.16/1.0 ± 0.23; n = 18, 21, 
23). Although neurons with Ago2 expression seem to have lower 
AMPA mEPSC frequency, we did not detect a statistical  difference 
between this group and either GFP and Ago2 + shScrambled con-
trols. We did not find significant differences in AMPA mEPSC 
amplitudes between any groups of neurons tested (Figure 6D; 
GFP/Ago2/Ago2 + shScrambled/shGluR2-1/Ago2 + shGluR2-1/
shGluR2-2/Ago2 + shGluR2-2: −8.79 ± 0.56/−7.97 ± 0.55/−9.15 ±
0.59/−10.52 ± 0.89/−9.14 ± 0.96/−10.26 ± 1.10/−7.77 ± 0.96, 
n = 18, 21, 23, 25, 24, 21, 20).
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DISCUSSION
RNAi is an evolutionarily conserved mechanism that has been devel-
oped into one of the most powerful genetic tools to inhibit gene 
expression in vivo. Compared to traditional knockout technology 
which is normally expensive, time consuming and only available 
for a limited number of species, RNAi methodology provides a 
rapid route to gene silencing, is relatively inexpensive, is applica-
ble to a wide range of animal and plant species and requires only 
FIguRe 6 | Ago2 expression enhances RNAi reduction of AMPA 
receptor-mediated synaptic responses in vivo. Whole-cell recordings were 
made from CNS neurons of Xenopus tadpoles transfected with pSi construct 
expressing shRNAs targeting the GluR2 subunit of AMPA receptor with or 
without Ago2 co-expression. (A) Diagram of the pSi constructs containing 
EnU6-shGluR2s for GluR2 knockdown, Ago2 for RNAi enhancement and GFP 
for cell identification. (B) Representative traces of spontaneous AMPA mEPSCs, 
superimposed from 30 consecutive traces. Cells co-expressing Ago2 with 
shGluR2-1 or shGluR2-2 (red) appear to have fewer mEPSCs than cells 
expressing shGluR2-1 or shGluR2-2 alone (black) and other control (green) 
traces. (C) Frequency of AMPA mEPSC in neurons transfected with pSi 
construct expressing shGluR2s with Ago2 (red) is significantly less than cells 
transfected with the pSi construct expressing shScrambled + Ago2 or GFP alone 
((green) and neurons expressing shGluRs only (black) (p < 0.05, ANOVA). 
Neurons expressing shGluR2s without Ago2 co-expression (black) have mEPSC 
frequency comparable to controls transfected with shScrambled + Ago2 and 
GFP alone (green). Neurons expressing GFP alone, Ago2 alone and 
shScrambled + Ago2 have comparable AMPA mEPSC frequencies. Dashed gray 
line indicates the averaged frequency of shScrambled control. (D) Amplitudes of 
AMPA mEPSC are not different between neurons transfected with GFP alone, 
Ago2 alone, and shScrambled or shGluR2s with or without Ago2 co-expression. 
Dashed gray line indicates the averaged amplitude of shScrambled control.
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short sequence  information for any gene of interest. However, the 
 inconsistent  efficacy of RNAi in gene knockdown remains an obstacle 
that limits its application. Here, we have evaluated RNAi efficacy and 
showed that co-expression of shRNA with Ago2 enhances knock-
down of both exogenous GFP expressed in cultured cell lines and 
intact animals and endogenous AMPA receptors in CNS neurons 
of intact animals. Ago2 expression does not affect gross dendritic 
arbor morphology in CNS neurons of Xenopus tadpoles. These data 
together suggest that co-expression of Ago2 with shRNAs can be a 
simple method to enhance RNAi efficiency in intact animals.
RATE-LIMITINg COMpONENTS Of ENDOgENOUS RNAi MACHINERy
We hypothesized that the endogenous RNAi machinery may be 
expressed at low levels or occupied by endogenous microRNA 
processing, thereby limiting RNAi performance in intact animals. 
Once introduced into cells, the exogenous shRNAs would not be 
able to compete with endogenous microRNA for these shared 
molecules required for efficient RNAi, resulting in low protein 
knockdown efficiency in neurons of Xenopus tadpole. Increasing 
the amount of these limiting factors would then provide better 
capacity for a cell to execute targeted mRNA degradation and gene 
silencing.
Previous studies have tested whether key components of the 
RNAi machinery, including Drosha, Exportin, Dicer and Ago pro-
teins, limit RNAi function in cultured cells (Diederichs et al., 2008; 
Mikuma et al., 2004; Yi et al., 2005), and suggested that Ago2 can 
increase RNAi efficiency without induction of off-target effects 
(Diederichs et al., 2008). Consistent with this, we found that a 
synthesized siRNA against GFP, which mimics the ∼22-mer Dicer 
products, does not show significant RNAi knockdown in Xenopus 
tadpole neurons (data not shown). These data suggest that the 
major limiting factor for knockdown efficiency in this system is 
downstream of Dicer. Indeed, we found that Ago2 co-expression 
with shRNA enhances knockdown of exogenous GFP and endog-
enous GluR2 subunit-containing AMPA receptors in Xenopus brain 
cells (Figures 4 and 6). These data demonstrate that exogenous 
expression of Ago2 can increase RNAi efficiency and suggest that 
it is a rate-limiting factor in shRNA-induced gene knockdown in 
CNS neurons of intact Xenopus.
It is interesting to note that the three shGFPs that we know 
work efficiently in HEK293, HeLa, COS7 and NIH3T3 cell lines 
(Figure 2; Tables 1 and 2), function relatively poorly in intact 
animals (Figure 4). In fact, without Ago2 co-expression, shGFPs 
only reduce exogenous GFP levels 15–20% compared to control 
neurons in Xenopus tadpoles. With Ago2 expression, we revealed 
moderate yet significant knockdown (∼34–38%) for exogenous 
GFP in Xenopus (Figure 4). When we examined the endogenous 
neuronal protein, GluR2, we only detected a significant reduc-
tion of AMPA mEPSC frequency when Ago2 was co-expressed 
with shGluR2s (Figure 6). AMPA mEPSC frequency is reduced 
to 0 in some neurons, although other neurons still have mEP-
SCs frequencies comparable to control neurons. This may reflect 
cell to cell variation in RNAi efficiency or variation in receptor 
subunit composition, and therefore sensitivity to loss of GluR2, 
at excitatory synapses. The differential efficiency of RNAi in intact 
animals compared to cells lines suggests that there might be mul-
tiple components of the RNAi machinery that are expressed at 
low levels or are occupied by endogenous microRNA processing 
in intact animals.
RNAi ENHANCEMENT By ARTIfICIAL microRNA-BASED HAIRpINS
Other strategies to improve RNAi efficiency are based on the pres-
entation and structure of the shRNA. Based on the identification 
and understanding of natural microRNAs, it is possible to introduce 
artificial microRNA that not only preserves the overall structure of 
the primary microRNA but also incorporates engineered sequences 
for specific gene silencing (Zeng et al., 2002). It is thought that the 
conserved structure from the primary microRNA transcript allows 
the artificial microRNA to enter the RNAi pathway more efficiently 
and can be subsequently processed into siRNA more effectively 
to yield higher RNAi efficacy. Indeed, shRNA derived from the 
primary microRNA-30 design yields more than a 10-fold increase 
in siRNA production and results in increased RNAi efficiency com-
pared to shRNA in cultured cells (Silva et al., 2005).
We find that two out of three shRNAmir30 constructs tested 
improve GFP knockdown. One possible explanation for lack of 
knockdown with shGFP-3mir30 is that some target sequences might 
interfere with the endogenous microRNA processing, such as 
Drosha cleavage, which affects the yield of siRNAs. Alternatively, 
shRNA and shRNAmir30 might be handled differently in the RNAi 
machinery even though they have identical shRNA sequences.
In addition, although shRNAmir30 and Ago2 co-expression with 
shRNA each enhanced RNAi efficiency individually, we did not 
see a synergistic effect on GFP knockdown when we expressed 
shGFPmir30 and Ago2 together in HEK293 cells. Interestingly, the 
poor GFP knockdown efficiency previously seen with shGFP-3mir30 
was dramatically improved by ectopic Ago2 expression (Figure 3). 
These data suggest that co-expression of Ago2 is more effective 
than shRNAmir30 at enhancing GFP knockdown and that Ago2 co-
expression can be applied more consistently without concern for 
shRNA sequence selectivity.
fUNCTIONAL ASSESSMENT Of NEURONAL RNAi
AMPA receptors, the major excitatory neurotransmitter receptors 
in the CNS, are tetramers composed of four subunits, GluR1-4. The 
GluR2 subunit is thought to be present in the majority of synap-
tic AMPA receptors which are predominately made of GluR2 and 
GluR1 or GlurR2 and GluR3 (Hollmann and Heinemann, 1994; 
Rosenmund et al., 1998; Wenthold et al., 1996). In Xenopus and 
rodents, blocking trafficking of GluR2-subunit containing AMPA 
receptors into synapses decreases AMPA receptor-mediated syn-
aptic inputs and interferes with neuronal plasticity and circuit 
function (Haas et al., 2006; Rumpel et al., 2005; Shi et al., 2001; 
Takahashi et al., 2003). In addition, GluR2 knockdown decreases 
spine number whereas GluR2 overexpression increases spine 
number in cultured hippocampal neurons (Passafaro et al., 2003). 
Therefore, reduced synaptic GluR2-containing receptors results 
in a reduction in excitatory synapse number and AMPA receptor 
mediated currents. We chose to test the efficacy of RNAi against 
an endogenous neuronal protein using GluR2, based on the afore-
mentioned data in this system and others, and based on the highly 
quantitative nature of functional recording of mEPSCs.
To test whether co-expression of Ago2 enhances RNAi in 
intact animals, we designed shRNAs against GluR2 and recorded 
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 spontaneous AMPA receptor mediated mEPSC as a functional 
 indicator for GluR2 knockdown. Indeed, when we introduced 
shGluR2 together with Ago2 in tectal neurons, AMPA receptor 
mediated mEPSC frequency was significantly reduced compared to 
control neurons transfected with GFP alone, or shScrambled + Ago2 
and importantly, neurons transfected with shGluR2 alone. The data 
provide strong evidence that ectopically expressed Ago2 enhances 
RNAi efficacy in CNS neuron in vivo. The amplitude of AMPA 
mEPSCs was not different from controls, suggesting that there 
might be a threshold number of AMPA receptors which is required 
to maintain a synapse. RNAi-mediated decreases in synaptic recep-
tor numbers may cause synapses to fall below a requisite level of 
synaptic transmission so that the functional synapse, detected here 
by spontaneous release of transmitter, is lost.
pROMOTER SELECTION AND fUTURE pERSpECTIvES
shRNAs introduced into cells by vector-based expression are transcribed 
by either RNA polymerase III (pol III) or polymerase II (pol II) promot-
ers (Huang et al., 2006; Paddison et al., 2004b). The pol III  promoters 
usually direct higher levels of shRNA expression for effective gene silenc-
ing and their smaller size facilitates cloning and packaging into viral 
vectors. We tested the two most commonly used pol III promoters, 
U6 and H1 promoters in driving shGFP expression for gene silencing. 
Consistent with previous findings (Paddison et al., 2004b), we found 
that U6 or H1 promoters result in comparable GFP knockdown in cell 
lines. Adding an enhancer from the CMV promoter in front of the U6 
promoter, which was previously shown to increase the U6 promoter 
activity and shRNA synthesis (Xia et al., 2003), did not yield higher 
GFP knockdown compared to U6 or H1 promoters alone. These results 
suggest that the promoter activities of U6 and H1 are not rate-limiting 
for RNAi efficacy in the systems we tested.
Compared to pol III promoters, the application of pol II promot-
ers for RNAi-mediated gene silencing is limited due to its lower 
shRNA expression activities. Even the strong CMV promoter has 
lower RNAi efficacy compared to pol III promoters, such as the 
H1 or U6 promoters (Paddison et al., 2004b), however, the com-
petence of pol II promoter to drive shRNA in a tissue-specific 
manner can be beneficial in studying gene function (Rao et al., 
2006) and gene therapy (Giering et al., 2008) in specific types 
of cells or tissues. Several promoters, for example the calcium/ 
calmodulin-dependent protein kinase II, glutamic acid decarboxy-
lase 67 and tyrosine hydroxylase promoters are well characterized 
to have distinct expressions in pyramidal neurons, GABAergic neu-
rons and dopaminergic neurons, respectively (Banerjee et al., 1992; 
Makinae et al., 2000; Mima et al., 2001). Our strategy to enhance 
RNAi efficacy by co-expression of Ago2 with shRNAs can be applied 
to facilitate RNAi when these relative weak pol II promoters are 
used for cell-type specific expression. In addition, since natural 
microRNAs are transcribed predominantly by pol II promoters 
(Cai et al., 2004; Lee et al., 2004), and pol II promoters have been 
shown to drive artificial shRNAmir30 efficiently (Silva et al., 2005), 
an alternative way to achieve cell-type specific gene silencing is to 
utilize shRNAmir30 under the control of pol II promoters.
Antisense morpholino oligonucleotides provide high levels 
of protein knockdown in frogs and fish (Anichtchik et al., 2008; 
Bestman and Cline, 2008; Chiu et al., 2008; Kenwrick et al., 2004; 
Nakaya et al., 2008; Wang and Poo, 2005), and this method on the 
whole is still more efficient than RNAi for protein knockdown in 
Xenopus. Nevertheless, a principle advantage of the RNAi method 
is the possibility of having spatial and temporal control of pro-
tein knockdown by use of cell type specific and regulatable pol II 
promoters to drive shRNA and Ago2. This provides significant 
opportunity to probe protein function that is not possible with 
morpholinos. Application of RNAi and further improvement on its 
use in intact animals is a valuable molecular strategy for exploring 
physiological gene functions in specific types of neurons within 
brain circuits with the potential for a therapeutic application in 
the treatment of neurological diseases.
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